Literature DB >> 4561347

Differential inhibition of coliphage MS2 protein synthesis by ribosome-directed antibiotics.

M Kozak, D Nathans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4561347     DOI： 10.1016/0022-2836(72)90162-3

Source DB:  PubMed          Journal:  J Mol Biol        ISSN： 0022-2836            Impact factor:   5.469


× No keyword cloud information.
  8 in total

1.  Specific, efficient, and selective inhibition of prokaryotic translation initiation by a novel peptide antibiotic.

Authors:  Letizia Brandi; Attilio Fabbretti; Anna La Teana; Monica Abbondi; Daniele Losi; Stefano Donadio; Claudio O Gualerzi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-27       Impact factor: 11.205

2.  Structural analysis of kasugamycin inhibition of translation.

Authors:  Barbara S Schuwirth; J Michael Day; Cathy W Hau; Gary R Janssen; Albert E Dahlberg; Jamie H Doudna Cate; Antón Vila-Sanjurjo
Journal:  Nat Struct Mol Biol       Date:  2006-09-24       Impact factor: 15.369

3.  Kasugamycin-resistant mutants of Bacillus subtilis.

Authors:  A Tominaga; Y Kobayashi
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

4.  Discriminatory ribosome rebinding of isolated regions of protein synthesis initiation from the ribonucleic acid of bacteriophage R17.

Authors:  J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

5.  Inhibitory action of erythromycin on bacteriophage SPO1 multiplication in sporulating cells of Bacillus subtilis 168.

Authors:  H Hirochika
Journal:  Mol Gen Genet       Date:  1980

Review 6.  Context-Specific Action of Ribosomal Antibiotics.

Authors:  Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Annu Rev Microbiol       Date:  2018-06-15       Impact factor: 15.500

7.  Insights into the Stress Response Triggered by Kasugamycin in Escherichia coli.

Authors:  Christian Müller; Lena Sokol; Oliver Vesper; Martina Sauert; Isabella Moll
Journal:  Antibiotics (Basel)       Date:  2016-06-01

8.  The context of the ribosome binding site in mRNAs defines specificity of action of kasugamycin, an inhibitor of translation initiation.

Authors:  Yan Zhang; Nikolay A Aleksashin; Dorota Klepacki; Caleb Anderson; Nora Vázquez-Laslop; Carol A Gross; Alexander S Mankin
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.